Genocea Biosciences, Inc. announced that Michael Higgins has joined the company's board of directors. Mr. Higgins is an experienced biotechnology executive and is currently entrepreneur-in-residence at Polaris Venture Partners. He previously served as chief operating officer and chief financial officer at Ironwood Pharmaceuticals from 2003 to 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 58 | |
+46.19% | 5.57TCr | |
-6.14% | 3.96TCr | |
+39.69% | 3.99TCr | |
-6.65% | 2.82TCr | |
+12.33% | 2.63TCr | |
-21.78% | 1.89TCr | |
-0.35% | 1.21TCr | |
+24.18% | 1.21TCr | |
+28.38% | 1.22TCr |
- Stock Market
- Equities
- GNCAQ Stock
- News Genocea Biosciences, Inc.
- Genocea Biosciences, Inc. Appoints Michael Higgins as Directors